This year has seen significant accomplishments for both ICO
North America and ICO
Nasdaq: DYAX) announced today that it has granted a non-exclusive license to its proprietary phage display libraries to ICOS Corporation (Nasdaq: ICOS) for the discovery and development of therapeutic antibodies.
Such forward-looking statements are based on current expectations, estimates and projections about the industry, management beliefs and certain assumptions made by the managements of ICOS and Lilly.
ICOS intends to file a revised definitive proxy statement and other documents regarding the proposed acquisition of ICOS by Lilly with the Securities and Exchange Commission (the "SEC").
The revised Agreement and Plan of Merger provides that Lilly will acquire all of the outstanding common stock of ICOS for a purchase price of $34 per share in cash, increased from the previous $32 per share.
ICOS' board of directors points out that ICOS will continue to be subject to European and Belgian laws applicable to publicly listed companies, including the Euronext rules.
ICOS Vision Systems Corporation NV can be found on the World Wide Web at www.
ICOS Corporation (ICOS) (NASDAQ: ICOS), announced today that it has signed a definitive agreement to be acquired by Eli Lilly and Company (Lilly) (NYSE: LLY).
Noels said, "For about 25 years, ICOS has consistently executed a growth strategy of sustaining market leadership, increasing penetration of established market segments and expanding addressable market.
LEUVEN, Belgium -- ICOS Vision Systems Corporation NV (Nasdaq and Euronext: IVIS), a leading supplier of inspection solutions for the semiconductor industry and IMEC, a world-leading independent research center in nanoelectronics and nanotechnology, have agreed to work together under a two-year Joint Exploration and Development Program (JEDP), in the field of inspection and metrology for three dimensional (3D) packaging.
ICOS Corporation (Nasdaq:ICOS) will announce its 2006 second quarter financial results on Thursday, August 3, 2006, after the market close.
HEVERLEE, Belgium -- ICOS Vision Systems Corporation NV (NASDAQ:IVIS) (EURONEXT: IVIS), a world leader in vision solutions, will issue a press release announcing its second quarter results at approximately 12:00 a.